美股A股
StockGist
Back
6-K2026-05-14· grok-4-1-fast-non-reasoning

UPC · Universe Pharmaceuticals Inc.

0001213900-26-056617

SEC filing

Summary

Universe Pharmaceuticals INC granted 71,890 Class A and 12,610 Class B ordinary shares to CEO Gang Lai under its 2026 Equity Incentive Plan as compensation for past services.

Key takeaways

Full analysis

The grant of 84,500 total shares under the newly adopted 2026 Equity Incentive Plan represents a significant equity allocation to CEO Gang Lai, who received nearly all available shares as compensation for prior contributions. This issuance increases his beneficial ownership to 75.0% of the company's voting power, further concentrating control with management. With total outstanding shares now at 631,761 Class A and 16,077 Class B, the dilution effect is limited but reinforces alignment of CEO interests with shareholders through equity incentives.